251 related articles for article (PubMed ID: 30501602)
1. Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy.
Sales ME; Español AJ; Salem AR; Pulido PM; Sanchez Y; Sanchez F
Curr Clin Pharmacol; 2019; 14(2):91-100. PubMed ID: 30501602
[TBL] [Abstract][Full Text] [Related]
2. Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors.
Salem AR; Martínez Pulido P; Sanchez F; Sanchez Y; Español AJ; Sales ME
Int Immunopharmacol; 2020 Jul; 84():106514. PubMed ID: 32311671
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer.
Sales ME
Curr Pharm Des; 2016; 22(14):2170-7. PubMed ID: 26924207
[TBL] [Abstract][Full Text] [Related]
4. Participation of non-neuronal muscarinic receptors in the effect of carbachol with paclitaxel on human breast adenocarcinoma cells. Roles of nitric oxide synthase and arginase.
Español AJ; Salem A; Rojo D; Sales ME
Int Immunopharmacol; 2015 Nov; 29(1):87-92. PubMed ID: 25812766
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer: Muscarinic receptors as new targets for tumor therapy.
Español A; Salem A; Sanchez Y; Sales ME
World J Clin Oncol; 2021 Jun; 12(6):404-428. PubMed ID: 34189066
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor agonists and antagonists: effects on cancer.
Spindel ER
Handb Exp Pharmacol; 2012; (208):451-68. PubMed ID: 22222710
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
Verma S; Kumar A; Tripathi T; Kumar A
J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
[TBL] [Abstract][Full Text] [Related]
8. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
Greig NH; Reale M; Tata AM
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):123-41. PubMed ID: 23597304
[TBL] [Abstract][Full Text] [Related]
9. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.
Zhang W; Basile AS; Gomeza J; Volpicelli LA; Levey AI; Wess J
J Neurosci; 2002 Mar; 22(5):1709-17. PubMed ID: 11880500
[TBL] [Abstract][Full Text] [Related]
10. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.
Moran SP; Maksymetz J; Conn PJ
Trends Pharmacol Sci; 2019 Dec; 40(12):1006-1020. PubMed ID: 31711626
[TBL] [Abstract][Full Text] [Related]
11. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
Digby GJ; Shirey JK; Conn PJ
Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.
Ali O; Tolaymat M; Hu S; Xie G; Raufman JP
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450835
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic acetylcholine receptors as CNS drug targets.
Langmead CJ; Watson J; Reavill C
Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approaches to targeting muscarinic acetylcholine receptors.
Matera C; Tata AM
Recent Pat CNS Drug Discov; 2014; 9(2):85-100. PubMed ID: 25413004
[TBL] [Abstract][Full Text] [Related]
15. Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase.
Minic J; Molgó J; Karlsson E; Krejci E
Eur J Neurosci; 2002 Feb; 15(3):439-48. PubMed ID: 11876771
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease.
Clader JW; Wang Y
Curr Pharm Des; 2005; 11(26):3353-61. PubMed ID: 16250841
[TBL] [Abstract][Full Text] [Related]
17. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.
Threlfell S; Clements MA; Khodai T; Pienaar IS; Exley R; Wess J; Cragg SJ
J Neurosci; 2010 Mar; 30(9):3398-408. PubMed ID: 20203199
[TBL] [Abstract][Full Text] [Related]
18. The importance of muscarinic receptors in domestic animal diseases and therapy: Current and future perspectives.
Abraham G
Vet J; 2016 Feb; 208():13-21. PubMed ID: 26654844
[TBL] [Abstract][Full Text] [Related]
19. The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
Español AJ; Salem A; Di Bari M; Cristofaro I; Sanchez Y; Tata AM; Sales ME
PLoS One; 2020; 15(9):e0226450. PubMed ID: 32911509
[TBL] [Abstract][Full Text] [Related]
20. Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems.
Furlan I; Godinho RO
Br J Pharmacol; 2005 Oct; 146(3):389-96. PubMed ID: 16041403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
